Simultaneously, some clinical studies have shown potential usefulness of some well-known and widely recognized cardiovascular biomarkers, such as BNP, NT-proBNP, hsTnT, sST2, osteopontin, or serum uric acid, in diagnosing and prognosing the outcome of pulmonary hypertension. This evidence concerns the gene SPP1 and pulmonary hypertension.